Private Advisor Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $994K | Sell |
15,822
-1,074
| -6% | -$74.8K | ﹤0.01% | 1424 |
|
|
2025
Q4 | $1.12M | Buy |
16,896
+11,735
| +227% | +$759K | 0.01% | 1346 |
|
|
2025
Q3 | $347K | Sell |
5,161
-1,069
| -17% | -$84.6K | ﹤0.01% | 1988 |
|
|
2025
Q2 | $544K | Sell |
6,230
-7,231
| -54% | -$567K | ﹤0.01% | 1640 |
|
|
2025
Q1 | $919K | Sell |
13,461
-1,688
| -11% | -$138K | 0.01% | 1288 |
|
|
2024
Q4 | $1.18M | Buy |
15,149
+3,831
| +34% | +$284K | 0.01% | 1145 |
|
|
2024
Q3 | $759K | Buy |
11,318
+608
| +6% | +$49.9K | ﹤0.01% | 1388 |
|
|
2024
Q2 | $1.21M | Buy |
10,710
+891
| +9% | +$113K | 0.01% | 1087 |
|
|
2024
Q1 | $1.36M | Sell |
9,819
-953
| -9% | -$120K | 0.01% | 1004 |
|
|
2023
Q4 | $1.34M | Buy |
10,772
+2,329
| +28% | +$238K | 0.01% | 959 |
|
|
2023
Q3 | $788K | Sell |
8,443
-10,591
| -56% | -$1.19M | 0.01% | 1161 |
|
|
2023
Q2 | $2.45M | Buy |
19,034
+10,622
| +126% | +$1.28M | 0.02% | 639 |
|
|
2023
Q1 | $977K | Buy |
+8,412
| New | +$942K | 0.01% | 1004 |
|
|
2022
Q4 | – | Sell |
-7,936
| Closed | -$639K | – | 1740 |
|
|
2022
Q3 | $639K | Sell |
7,936
-6,273
| -44% | -$531K | 0.01% | 1122 |
|
|
2022
Q2 | $1.06M | Buy |
14,209
+2,245
| +19% | +$205K | 0.01% | 1036 |
|
|
2022
Q1 | $1.53M | Buy |
11,964
+852
| +8% | +$93.2K | 0.01% | 912 |
|
|
2021
Q4 | $1.49M | Sell |
11,112
-3,856
| -26% | -$554K | 0.01% | 935 |
|
|
2021
Q3 | $2.05M | Buy |
14,968
+6,292
| +73% | +$793K | 0.01% | 872 |
|
|
2021
Q2 | $926K | Buy |
8,676
+416
| +5% | +$40K | 0.01% | 1104 |
|
|
2021
Q1 | $742K | Sell |
8,260
-1,072
| -11% | -$101K | 0.01% | 1133 |
|
|
2020
Q4 | $863K | Buy |
9,332
+788
| +9% | +$70.4K | 0.01% | 969 |
|
|
2020
Q3 | $874K | Sell |
8,544
-8,488
| -50% | -$887K | 0.01% | 837 |
|
|
2020
Q2 | $1.73M | Buy |
17,032
+10,040
| +144% | +$898K | 0.02% | 577 |
|
|
2020
Q1 | $470K | Buy |
+6,992
| New | +$435K | 0.01% | 918 |
|
|
2018
Q4 | – | Sell |
-9,712
| Closed | -$347K | – | 1407 |
|
|
2018
Q3 | $347K | Buy |
+9,712
| New | +$301K | 0.01% | 1153 |
|
|
2016
Q1 | – | Sell |
-17,116
| Closed | -$350K | – | 1052 |
|
|
2015
Q4 | $350K | Sell |
17,116
-1,596
| -9% | -$33.2K | 0.02% | 725 |
|
|
2015
Q3 | $402K | Sell |
18,712
-1,252
| -6% | -$27.9K | 0.02% | 644 |
|
|
2015
Q2 | $399K | Sell |
19,964
-292
| -1% | -$5.13K | 0.02% | 679 |
|
|
2015
Q1 | $316K | Buy |
+20,256
| New | +$306K | 0.02% | 719 |
|
Other funds holding DXCM
VCM
VPM
Private Advisor Group's DXCM Position: Q1 2026 in Review
Private Advisor Group reduced its DexCom (DXCM) stake by 6.4% in Q1 2026, selling an estimated $74.8K and leaving 15,822 shares worth $994K. The position accounts for ﹤0.01% of the portfolio, ranked #1424.
Private Advisor Group first reported a position in DXCM in Q1 2015 and has held it in 29 quarters since. The position peaked at $2.45M in Q2 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Private Advisor Group held 15,822 shares of DexCom worth $994K as of Q1 2026.
- Private Advisor Group sold 1,074 DexCom shares in Q1 2026, an estimated $74.8K.
- DexCom made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #1424 holding.
- Private Advisor Group first reported a position in DexCom in Q1 2015 and has held it in 29 quarters since.
- Private Advisor Group's DexCom position peaked at $2.45M in Q2 2023.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.